++
Content Update: High-Sensitivity Cardiac Troponins and Acute Myocardial Ischemia March 2021
Hs-cTns (high-sensitivity cardiac troponins) improve ability to detect acute coronary ischemia.
Type 1 and type 2 myocardial ischemia, and the use of Hs-cTns in ED patients with chest pain are discussed in important updates in the section “Serum Markers of Myocardial Injury.”
++
Cardiac Complications of COVID-19 June 2020
Acute Coronary Syndrome and STEMI management present unique challenges during the COVID-19 pandemic. Treatment options require close collaboration between EMS systems, emergency departments, and cardiology services. See addition ‘Cardiac Complications of COVID-19’ in the section SPECIAL POPULATIONS at the end of this chapter.
++
Ischemic heart disease is the leading cause of death among adults in the United States, with more than 400,000 people dying annually. Atherosclerotic disease of the epicardial coronary arteries—termed coronary artery disease—accounts for the vast majority of patients with ischemic heart disease. The predominant symptom of coronary artery disease is chest pain, and patient concern over potential acute heart disease contributes to the >8 million visits each year to U.S. EDs. In a typical adult ED population with acute chest pain, about 15% of patients will have an acute coronary syndrome (ACS). ACS encompasses unstable angina through acute myocardial infarction (AMI). Of patients with an ACS, approximately one third have an AMI, and the remainder have unstable angina.
++
The three principal presentations of unstable angina are listed in Table 49-1.1 These definitions assume that the anginal chest pain is due to ischemia, and this categorization does not apply to patients presenting to the ED with chest pain from other causes. During the initial ED assessment, it may not be possible to determine whether the patient has or will sustain permanent damage to the myocardium, has reversible ischemia (injury or unstable angina), or has a noncardiac cause of symptoms.
++++
The American College of Cardiology and American Heart Association have a tool for estimating the short-term risk for death or AMI in patients with unstable angina (Table 49-2).1
++